ID: ALA5270813

Max Phase: Preclinical

Molecular Formula: C16H12O6

Molecular Weight: 300.27

Associated Items:

Representations

Canonical SMILES:  C=Cc1cc2oc3cc(O)cc(O)c3c(=O)c2c(OC)c1O

Standard InChI:  InChI=1S/C16H12O6/c1-3-7-4-10-13(16(21-2)14(7)19)15(20)12-9(18)5-8(17)6-11(12)22-10/h3-6,17-19H,1H2,2H3

Standard InChI Key:  QFNWCLOENZLMOS-UHFFFAOYSA-N

Associated Targets(Human)

Alpha glucosidase 860 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 300.27Molecular Weight (Monoisotopic): 300.0634AlogP: 2.71#Rotatable Bonds: 2
Polar Surface Area: 100.13Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.51CX Basic pKa: CX LogP: 3.28CX LogD: 3.02
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.63Np Likeness Score: 1.75

References

1. Santos CMM, Freitas M, Fernandes E..  (2018)  A comprehensive review on xanthone derivatives as α-glucosidase inhibitors.,  157  [PMID:30282319] [10.1016/j.ejmech.2018.07.073]

Source